https://www.indianpharmapost.com/dr-reddys-launches-novel-recombinant-hepatitis-e-vaccine-hevaxin-in-india-187842026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-completes-acquisition-of-cidara-therapeutics-187962026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/avient-introduces-non-pfas-glidetech-formulations-for-catheters-187952026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/kelun-biotech-secures-ind-nod-for-innovative-cancer-therapy-skb105-in-china-187942026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/wuxi-biologics-secures-iso-20400-certification-187932026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/medera-doses-final-patient-in-high-dose-hfpef-gene-therapy-trial-187922026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/metavias-da-1726-shows-breakthrough-weight-loss-in-phase-1-trial-187912026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/incyte-eyes-first-line-nod-for-tafasitamab-in-aggressive-lymphoma-187902026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsks-nucala-approved-in-china-for-copd-with-high-eosinophils-187892026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-grants-priority-review-to-tzield-for-youngest-type-1-diabetes-patients-187882026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/subcutaneous-saphnelo-cuts-lupus-disease-activity-in-phase-iii-trial-187872026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/probiogen-zag-bio-seal-manufacturing-deal-to-fast-track-type-1-diabetes-therapy-into-clinic-187862026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-lal-pathlabs-launches-tech-driven-personalized-wellness-center-sovaaka-187852026-01-07T00:00:00+05:30always0.9https://www.indianpharmapost.com/reimagining-indias-pharmaceutical-sector-from-global-supplier-to-innovation-leader-187972026-01-07T00:00:00+05:30always0.9